Difference between revisions of "Committees"
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
* '''[[Steering Committee]]''' | * '''[[Steering Committee]]''' | ||
| − | :* '''[[CT Coordinating Committee]]''' | + | :* '''[[CT Volumetry tech ctte|CT Coordinating Committee]]''' |
| − | ::* [[CT Volumetry | + | ::* [[CT Volumetry Biomarker Ctte|CT Volumetry Biomarker Committee]] |
:::* Volumetry Algorithm Challenge TF | :::* Volumetry Algorithm Challenge TF | ||
:::* Small Lung Nodule TF | :::* Small Lung Nodule TF | ||
:::* QIBA/fNIH FDA Biomarker Qualification Partnership | :::* QIBA/fNIH FDA Biomarker Qualification Partnership | ||
| − | ::* [[ | + | ::* [[Lung Density Biomarker Ctte|Lung Density Biomarker Committee]] |
:::* Airway Measurement TF | :::* Airway Measurement TF | ||
| Line 16: | Line 16: | ||
:::* DW-MR TF | :::* DW-MR TF | ||
:::* DCE-MRI TF | :::* DCE-MRI TF | ||
| − | :::* MRE TF | + | :::* [[MRE_Biomarker_Ctte|MRE TF]] |
:::* Other TFs (DTI, DSC, Fat Fraction) | :::* Other TFs (DTI, DSC, Fat Fraction) | ||
::* [[FMRI tech ctte|fMRI Biomarker Committee]] | ::* [[FMRI tech ctte|fMRI Biomarker Committee]] | ||
| − | :* '''[[NM Coordinating Committee]]''' | + | :* '''[[FDG-PET tech ctte|NM Coordinating Committee]]''' |
| − | ::* [[FDG-PET Biomarker Committee]] | + | ::* [[FDG-PET Biomarker Ctte|FDG-PET Biomarker Committee]] |
:::* Profile Compliance TF | :::* Profile Compliance TF | ||
:::* FDG-PET UPICT TF | :::* FDG-PET UPICT TF | ||
:::* QIBA/fNIH FDA Biomarker Qualification Partnership | :::* QIBA/fNIH FDA Biomarker Qualification Partnership | ||
| − | ::* [[PET-Amyloid Biomarker Committee]] | + | ::* [[PET_Amyloid_Biomarker_Ctte|PET-Amyloid Biomarker Committee]] |
| − | ::* SPECT TF | + | ::* [[SPECT Biomarker Ctte (proposed)|SPECT TF]] |
| − | :* '''[[US Coordinating Committee]]''' | + | :* '''[[Ultrasound SWS tech ctte|US Coordinating Committee]]''' |
| − | ::* [[Ultrasound SWS | + | ::* [[Ultrasound SWS Biomarker Ctte|Ultrasound SWS Biomarker Committee]] |
:::* System Dependencies/Phantom Testing TF | :::* System Dependencies/Phantom Testing TF | ||
:::* Clinical Applications TF | :::* Clinical Applications TF | ||
Revision as of 17:59, 21 May 2015
QIBA Committee Structure Description
-
-
- Volumetry Algorithm Challenge TF
- Small Lung Nodule TF
- QIBA/fNIH FDA Biomarker Qualification Partnership
- Airway Measurement TF
-
-
-
- DW-MR TF
- DCE-MRI TF
- MRE TF
- Other TFs (DTI, DSC, Fat Fraction)
-
-
-
- Profile Compliance TF
- FDG-PET UPICT TF
- QIBA/fNIH FDA Biomarker Qualification Partnership
-
-
-
- System Dependencies/Phantom Testing TF
- Clinical Applications TF
-
| Committee | Co-chairs | ||
|---|---|---|---|
| QIBA Steering Committee | Daniel C. Sullivan, MD (QIBA Chair); Edward F. Jackson, PhD (QIBA Vice-Chair) | ||
| PDF-MRI Technical Committee | Marko Ivancevic, PhD; Edward F. Jackson, PhD; Gudrun Zahlmann, PhD | ||
| fMRI Technical Committee | Edgar (Ted) DeYoe, PhD; Cathy Elsinger, PhD; Jeffrey Petrella, MD | ||
| FDG-PET Technical Committee | Paul E. Kinahan, PhD; Ling X. Shao, PhD; Richard L. Wahl, MD | ||
| CT Volumetry Technical Committee | Samuel G. Armato III, PhD; Gregory V. Goldmacher, MD, PhD; Lawrence H. Schwartz, MD | ||
| COPD-Asthma Technical Committee | Philip F. Judy, PhD | ||
| Ultrasound SWS Technical Committee | Brian Garra, MD; Tim J. Hall, PhD; Andrzej (Andy) Milkowski, MS |